Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
empagliflozin (jardiance) (1 trial)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Nephropathies (Phase 2)
Kidney Diseases (Phase 2)
Renal Insufficiency, Chronic (Phase 2)
Trials (1 total)
Trial APIs (1 total)